Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long associated with ...

The FDA approved Zegfrovy for advanced non-small cell lung cancer with EGFR exon 20 mutations after chemotherapy.

FDA accelerates approval of sunvozertinib for advanced NSCLC with EGFR mutations, offering new hope for patients after ...

A new treatment option, Datroway (datopotamab deruxtecan or Dato-DXd), is now available for people with non-small cell lung ...

Recurrence means that cancer has come back after initial treatment and a period during which it could not be detected. Even ...

Benzaldehyde – a compound responsible for the aroma of almonds, apricots and figs – halts the growth and spread of ...

Prostate cancer is a significant health concern for men globally, with rising incidence and mortality rates. Early detection ...

The majority of patients with the most common advanced or metastatic cancers in the United States do not undergo ...

Radiologists are studying how artificial intelligence might help them catch lung cancer nodules at an earlier stage.

Dizal has received FDA approval for Zegfrovy to treat adults with locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations.